Langerhans cell histiocytosis: treatment strategies

J Craniofac Surg. 2014 May;25(3):1134-6. doi: 10.1097/SCS.0000000000000668.

Authors

Filippo Giovannetti¹, Ikenna Valentine Aboh, Glauco Chisci, Paolo Gennaro, Guido Gabriele, Flavia Cascino, Paolo Di Curzio, Giorgio Iannetti

Affiliation

¹ Department of Maxillofacial Surgery, "Sapienza" University of Rome, Rome, Italy Department of Maxillofacial Surgery, University of Siena, Siena, Italy Department of Maxillofacial Surgery, "Sapienza" University of Rome, Rome, Italy Department of Maxillofacial Surgery, "Sapienza" University of Rome, Rome, Italy Department of Maxillofacial Surgery University of Siena, Siena, Italy.

PMID: 24785749
DOI: 10.1097/SCS.0000000000000668

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Chemotherapy, Adjuvant
Child
Child, Preschool
Combined Modality Therapy
Diagnosis, Differential
Female
Follow-Up Studies
Histiocytosis, Langerhans-Cell / diagnosis*
Histiocytosis, Langerhans-Cell / drug therapy
Histiocytosis, Langerhans-Cell / pathology
Humans
Infant
Male
Mandibular Diseases / diagnosis*
Mandibular Diseases / drug therapy
Mandibular Diseases / pathology
Orbital Diseases / diagnosis*
Orbital Diseases / drug therapy
Orbital Diseases / pathology
Temporal Bone* / pathology
Young Adult